Education
About Us
Working with TipRanks
Follow Us
Entheon Biomedical Corp. (ENTBF)
:ENTBF
ENTBF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.04 - $0.29
Previous CloseN/A
Volume3.65K
Average Volume (3M)179.00
Market Cap
$1.11M
Enterprise Value$14.46M
Total Cash (Recent Filing)$525.16K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta1.78
Next Earnings
Jul 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,858,926
10 Day Avg. Volume299
30 Day Avg. Volume179
Financial Highlights & Ratios
PEG Ratio-19.86
Price to Book (P/B)8.70
Price to Sales (P/S)0.00
P/FCF Ratio-24.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Entheon Biomedical News
PremiumCompany Announcements
Entheon Biomedical Announces Board Changes
PremiumCompany Announcements
Entheon Biomedical Grants Incentive Stock Options to Directors
PremiumCompany Announcements
Entheon Biomedical Ends Acquisition Agreement with Mentis AI
PremiumCompany Announcements
Entheon Biomedical Secures $500,000 in Private Placement
PremiumCompany Announcements
Entheon Biomedical Announces New Private Placement FinancingPremiumCompany Announcements
Entheon Biomedical Completes $147.5K Private PlacementPremiumCompany Announcements
Entheon Biomedical’s Strategic Financing InitiativeOptions Prices
Currently, No data available
---
Ownership Overview
ENTBF FAQ
What was Entheon Biomedical Corp.’s price range in the past 12 months?
Entheon Biomedical Corp. lowest stock price was $0.04 and its highest was $0.29 in the past 12 months.
What is Entheon Biomedical Corp.’s market cap?
Entheon Biomedical Corp.’s market cap is $1.11M.
When is Entheon Biomedical Corp.’s upcoming earnings report date?
Entheon Biomedical Corp.’s upcoming earnings report date is Jul 29, 2025 which is in 38 days.
How were Entheon Biomedical Corp.’s earnings last quarter?
Currently, no data Available
Is Entheon Biomedical Corp. overvalued?
According to Wall Street analysts Entheon Biomedical Corp.’s price is currently Overvalued.
Does Entheon Biomedical Corp. pay dividends?
Entheon Biomedical Corp. does not currently pay dividends.
What is Entheon Biomedical Corp.’s EPS estimate?
Entheon Biomedical Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Entheon Biomedical Corp. have?
Entheon Biomedical Corp. has 13,858,926 shares outstanding.
What happened to Entheon Biomedical Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Entheon Biomedical Corp.?
Currently, no hedge funds are holding shares in ENTBF
Company Description
Entheon Biomedical Corp.
Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Technical Analysis
Cybin
―
Braxia Scientific
―
Lexston Life Sciences Corp.
―
Doseology Sciences
―
Lophos Holdings, Inc.
―